Apolipoprotein C‐III predicts cardiovascular events and mortality in individuals with type 1 diabetes and albuminuria

Corresponding Author

Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland

Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland

Department of Diabetes, Central Clinical School, Monash University, Melbourne, Victoria, Australia

Correspondence

Per-Henrik Groop, FinnDiane, Folkhälsan Research Center, Biomedicum Helsinki (C318b), Haartmaninkatu 8, FIN-00290, Helsinki, Finland.

View original article

0 0 0 0 0 0 0

Comments (0)